127 related articles for article (PubMed ID: 26876989)
1. Treatment-related toxicities in children with acute lymphoblastic leukaemia predisposition syndromes.
Schmiegelow K
Eur J Med Genet; 2016 Dec; 59(12):654-660. PubMed ID: 26876989
[TBL] [Abstract][Full Text] [Related]
2. Germline genetic variation in ETV6 and risk of childhood acute lymphoblastic leukaemia: a systematic genetic study.
Moriyama T; Metzger ML; Wu G; Nishii R; Qian M; Devidas M; Yang W; Cheng C; Cao X; Quinn E; Raimondi S; Gastier-Foster JM; Raetz E; Larsen E; Martin PL; Bowman WP; Winick N; Komada Y; Wang S; Edmonson M; Xu H; Mardis E; Fulton R; Pui CH; Mullighan C; Evans WE; Zhang J; Hunger SP; Relling MV; Nichols KE; Loh ML; Yang JJ
Lancet Oncol; 2015 Dec; 16(16):1659-66. PubMed ID: 26522332
[TBL] [Abstract][Full Text] [Related]
3. Advances in germline predisposition to acute leukaemias and myeloid neoplasms.
Klco JM; Mullighan CG
Nat Rev Cancer; 2021 Feb; 21(2):122-137. PubMed ID: 33328584
[TBL] [Abstract][Full Text] [Related]
4. Whole-exome sequencing of a rare case of familial childhood acute lymphoblastic leukemia reveals putative predisposing mutations in Fanconi anemia genes.
Spinella JF; Healy J; Saillour V; Richer C; Cassart P; Ouimet M; Sinnett D
BMC Cancer; 2015 Jul; 15():539. PubMed ID: 26201965
[TBL] [Abstract][Full Text] [Related]
5. Germline deletion of
Rampersaud E; Ziegler DS; Iacobucci I; Payne-Turner D; Churchman ML; Schrader KA; Joseph V; Offit K; Tucker K; Sutton R; Warby M; Chenevix-Trench G; Huntsman DG; Tsoli M; Mead RS; Qu C; Leventaki V; Wu G; Mullighan CG
Blood Adv; 2019 Apr; 3(7):1039-1046. PubMed ID: 30940639
[TBL] [Abstract][Full Text] [Related]
6. Intravenous pegylated asparaginase versus intramuscular native Escherichia coli L-asparaginase in newly diagnosed childhood acute lymphoblastic leukaemia (DFCI 05-001): a randomised, open-label phase 3 trial.
Place AE; Stevenson KE; Vrooman LM; Harris MH; Hunt SK; O'Brien JE; Supko JG; Asselin BL; Athale UH; Clavell LA; Cole PD; Kelly KM; Laverdiere C; Leclerc JM; Michon B; Schorin MA; Welch JJ; Lipshultz SE; Kutok JL; Blonquist TM; Neuberg DS; Sallan SE; Silverman LB
Lancet Oncol; 2015 Dec; 16(16):1677-90. PubMed ID: 26549586
[TBL] [Abstract][Full Text] [Related]
7. Genetic predisposition to acute lymphoblastic leukemia: Overview on behalf of the I-BFM ALL Host Genetic Variation Working Group.
Kratz CP; Stanulla M; Cavé H
Eur J Med Genet; 2016 Mar; 59(3):111-5. PubMed ID: 26699264
[TBL] [Abstract][Full Text] [Related]
8. Genetic predisposition in acute leukaemia.
Wiggins M; Stevenson W
Int J Lab Hematol; 2020 Jun; 42 Suppl 1():75-81. PubMed ID: 32115888
[TBL] [Abstract][Full Text] [Related]
9. Somatic and germline genomics in paediatric acute lymphoblastic leukaemia.
Pui CH; Nichols KE; Yang JJ
Nat Rev Clin Oncol; 2019 Apr; 16(4):227-240. PubMed ID: 30546053
[TBL] [Abstract][Full Text] [Related]
10. Next-generation-sequencing of recurrent childhood high hyperdiploid acute lymphoblastic leukemia reveals mutations typically associated with high risk patients.
Chen C; Bartenhagen C; Gombert M; Okpanyi V; Binder V; Röttgers S; Bradtke J; Teigler-Schlegel A; Harbott J; Ginzel S; Thiele R; Husemann P; Krell PF; Borkhardt A; Dugas M; Hu J; Fischer U
Leuk Res; 2015 Sep; 39(9):990-1001. PubMed ID: 26189108
[TBL] [Abstract][Full Text] [Related]
11. Predisposing germline mutations in high hyperdiploid acute lymphoblastic leukemia in children.
de Smith AJ; Lavoie G; Walsh KM; Aujla S; Evans E; Hansen HM; Smirnov I; Kang AY; Zenker M; Ceremsak JJ; Stieglitz E; Muskens IS; Roberts W; McKean-Cowdin R; Metayer C; Roux PP; Wiemels JL
Genes Chromosomes Cancer; 2019 Oct; 58(10):723-730. PubMed ID: 31102422
[TBL] [Abstract][Full Text] [Related]
12. Acute lymphoblastic leukaemia: a model for the pharmacogenomics of cancer therapy.
Cheok MH; Evans WE
Nat Rev Cancer; 2006 Feb; 6(2):117-29. PubMed ID: 16491071
[TBL] [Abstract][Full Text] [Related]
13. Recent advances in genetic predisposition to pediatric acute lymphoblastic leukemia.
Bloom M; Maciaszek JL; Clark ME; Pui CH; Nichols KE
Expert Rev Hematol; 2020 Jan; 13(1):55-70. PubMed ID: 31657974
[No Abstract] [Full Text] [Related]
14. [Individualized cancer treatment. Illustrated by acute lymphoblastic leukemia in children].
Schmiegelow K
Ugeskr Laeger; 2001 Feb; 163(8):1062-6. PubMed ID: 11242663
[TBL] [Abstract][Full Text] [Related]
15. Familial risks for childhood acute lymphocytic leukaemia in Sweden and Finland: far exceeding the effects of known germline variants.
Kharazmi E; da Silva Filho MI; Pukkala E; Sundquist K; Thomsen H; Hemminki K
Br J Haematol; 2012 Dec; 159(5):585-8. PubMed ID: 23025517
[TBL] [Abstract][Full Text] [Related]
16. Biology of childhood acute lymphoblastic leukemia.
Bhojwani D; Yang JJ; Pui CH
Pediatr Clin North Am; 2015 Feb; 62(1):47-60. PubMed ID: 25435111
[TBL] [Abstract][Full Text] [Related]
17. [Genetic background and treatment of pediatric ALL].
Kato M
Rinsho Ketsueki; 2018; 59(10):2268-2272. PubMed ID: 30305535
[TBL] [Abstract][Full Text] [Related]
18. Presence of clone-specific markers at birth in children with acute lymphoblastic leukaemia.
Hjalgrim LL; Madsen HO; Melbye M; Jørgensen P; Christiansen M; Andersen MT; Pallisgaard N; Hokland P; Clausen N; Ryder LP; Schmiegelow K; Hjalgrim H
Br J Cancer; 2002 Oct; 87(9):994-9. PubMed ID: 12434291
[TBL] [Abstract][Full Text] [Related]
19. Association of initial response to prednisone treatment in childhood acute lymphoblastic leukaemia and polymorphisms within the tumour necrosis factor and the interleukin-10 genes.
Lauten M; Matthias T; Stanulla M; Beger C; Welte K; Schrappe M
Leukemia; 2002 Aug; 16(8):1437-42. PubMed ID: 12145682
[TBL] [Abstract][Full Text] [Related]
20. Enrichment of cancer-predisposing germline variants in adult and pediatric patients with acute lymphoblastic leukemia.
Douglas SPM; Lahtinen AK; Koski JR; Leimi L; Keränen MAI; Koskenvuo M; Heckman CA; Jahnukainen K; Pitkänen E; Wartiovaara-Kautto U; Kilpivaara O
Sci Rep; 2022 Jun; 12(1):10670. PubMed ID: 35739278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
